Company Filing History:
1 out of 4,304 
1 out of 1 Years Active: 2025
Title: Lee-Wei Yang: Innovator in COVID-19 Treatment
Introduction
Lee-Wei Yang is a notable inventor based in Garland, TX (US). He has made significant contributions to the field of medical science, particularly in the fight against COVID-19. His innovative approach has led to the development of a unique method for treating SARS-CoV2-related diseases.
Latest Patents
Lee-Wei Yang holds a patent for a method and combination for the suppression of the COVID-19 virus. This patent describes a method for treating a SARS-CoV2 3CL-related disease by blocking the dimerization of the 3C-like main protease (3CL) of the SARS-CoV2 virus. The method involves administering a first agent that binds to a first binding site of the SARS-CoV2 3CL complex and a second agent that binds to a second binding site, which are functionally different sites in the three-dimensional structure of the complex. This pharmaceutical combination aims to suppress SARS-CoV2, thereby alleviating COVID-19.
Career Highlights
Throughout his career, Lee-Wei Yang has worked with esteemed institutions such as Tsinghua University and Praexisio Taiwan, Inc. His work has been pivotal in advancing research and development in the medical field.
Collaborations
Lee-Wei Yang has collaborated with notable colleagues, including Kun-Lin Tsai and Bang-Chieh Huang. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Lee-Wei Yang's innovative contributions to the treatment of COVID-19 highlight his role as a significant inventor in the medical field. His patent for a method to suppress the virus showcases the potential for scientific advancements in combating global health crises.